Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Aug 23;172(2):487–496. doi: 10.1007/s10549-018-4916-6

Table 5.

The relationship of BPE to CD44+/CD24−,TGFβ, ERα, and PR in post-menopausal patients

Variable Category BPE
ra pa
Min (n = 11) Mild (n = 12) Mod (n = 6) Marked (n = 3)
CD44+/CD24−b 3 (27%) 4 (33%) 2 (33%) 0 (0%) − 0.06  0.75
+ 8 (73%) 8 (67%) 4 (67%) 3 (100%)
TGFβb 1 (9%) 1 (8%) 1 (17%) 0 (0%) − 0.01  0.97
+ 10 (91%) 11 (92%) 5 (83%) 3 (100%)
ERαc < 5 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0.10 0.59
5− 0 (0%) 0 (0%) 0 (0%) 0 (0%)
10− 0 (0%) 0 (0%) 0 (0%) 0 (0%)
20− 5 (45%) 5 (42%) 1 (17%) 1 (33%)
30+ 6 (55%) 7 (58%) 5 (83%) 2 (67%)
PRc < 5 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0.10 0.57
5− 0 (0%) 0 (0%) 0 (0%) 0 (0%)
10− 2 (18%) 1 (8%) 0 (0%) 0 (0%)
20− 5 (45%) 9 (75%) 4 (67%) 2 (67%)
30+ 4 (36%) 2 (17%) 2 (33%) 1 (33%)

BPE measurement made by JSS

a

Non-parametric Spearman correlation (r) and associated significance level (p)

b

Membranous staining of TDLU epithelial cells

c

% nuclear staining of TDLU epithelial cells